SCHEMBL21940472

SCHEMBL21940472

Nc1cc(OC2CCOC2)nc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 7/20 0.41
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
KRAS P01116 2/20 0.40
CYP2C8 P10632 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
KCNH2 Q12809 2/20 0.40
CRBN Q96SW2 1/20 0.40
AKT1 P31749 1/20 0.40
PIK3CA P42336 1/20 0.40
MTOR P42345 1/20 0.40
HDAC6 Q9UBN7 1/20 0.37
GRM5 P41594 3/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
SYK P43405 3/20 0.37
P2RX3 P56373 2/20 0.37
P2RX2 Q9UBL9 2/20 0.37
JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21940466 0.92 SYK (0.44) SOS1HDAC6GRM5SYK
SCHEMBL21940313 0.78 MCHR1 (0.43) GRM5P2RX3P2RX2
SCHEMBL25409208 0.78 IRAK4 (0.41) SOS1CYP3A4CYP2D6CYP2C19KCNH2
SCHEMBL1263834 0.76 SOS1 (0.46) SOS1CYP3A4CYP2D6KRASCYP2C8
SCHEMBL5423541 0.76 SOS1 (0.46) SOS1CYP3A4CYP2D6KRASCYP2C8
SCHEMBL12382084 0.74 SOS1 (0.40) SOS1CYP3A4CYP2D6KRASCYP2C8
SCHEMBL17581321 0.73 PIK3CA (0.40) SOS1CYP3A4CYP2D6KRASCYP2C19
SCHEMBL6826046 0.73 PIK3CA (0.41) AKT1PIK3CAMTORMAPK8MAPK9
SCHEMBL24566255 0.73 TLR7 (0.35) PIK3CAMTOR
SCHEMBL17581280 0.73 PIK3CA (0.40) SOS1CYP3A4CYP2D6KRASCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423445-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2020-04-01 EP disclosed